ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting - PR Newswire

Additionally, data regarding VELCADE ®, as well as the investigational compounds ibrutinib and siltuximab, also have been accepted for presentation. Additional clinical study data were also accepted as publication-only abstracts. These studies were ...

Millennium and Takeda Announce Presentations for Key Investigational Molecules at American Society of Clinical Oncology Annual Meeting - Business Wire

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a first-in-class proteasome inhibitor, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals ...

Don't Miss Johnson & Johnson's Rebound - Seekingalpha.com

They are Procrit, used to increase red blood cell counts, particularly after chemotherapy, the schizophrenia drug Risperdal, Velcade, used to treat multiple myeloma, Concerta, used to treat attention-deficit disorder and other psychological conditions ...

Four Ways to Make Medicine More Like Facebook - Forbes

But it would be nice if we could count one or two of them as billionaires. We can’t. Even in cases such as the multiple myeloma drug Velcade, which helped keep former vice presidential candidate Geraldine Ferraro alive for years and owes its ...

Johnson & Johnson Could Leap $4 Higher By 2013 - Seekingalpha.com

International operational sales escalated 19.6% -- an even higher rate than recent quarters. Contributing to positive sales results was Remicade and Velcade, plus newly launched products Zytiga, Stelara, and Incivo (telaprevir), an antiviral protease ...

Aeterna Zentaris Regains North American Rights for Perifosine from Keryx - TradersHuddle.com

1), double-blind trial comparing the efficacy and safety of perifosine to placebo when combined with bortezomib (Velcade®) and dexamethasone in approximately 400 patients with relapsed or relapsed/refractory multiple myeloma. The primary endpoint is ...